Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Royce W. Waltrip"'
Publikováno v:
Int J MS Care
Background: Treatments for multiple sclerosis (MS) relapse include intravenous corticosteroids and repository corticotropin injection. Despite available treatment, in the Multiple Sclerosis in America 2017 survey, only 47% of patients reported always
Autor:
Andrew R. Rava, Laura S. Gold, Keith R Fry, Tara A. Nazareth, Ryan N. Hansen, Tzy-Chyi Yu, Nancy Mahler, Royce W. Waltrip
Publikováno v:
Pediatric Health, Medicine and Therapeutics
Laura S Gold,1,2 Tara A Nazareth,3 Tzy-Chyi Yu,3 Keith R Fry,3 Nancy Ho Mahler,3 Andrew Rava,3 Royce W Waltrip II,3 Ryan N Hansen2,4 1Department of Radiology, University of Washington, Seattle, WA, USA; 2CHOICE Institute, School of Pharmacy, Universi
Autor:
Tara A. Nazareth, Andrew R. Rava, Royce W. Waltrip, Kristine Zerkowski, Leslie B. Herbert, Edward N. Banfe, Jackie L. Polyakov
Publikováno v:
Multiple Sclerosis and Related Disorders. 26:219-234
Underestimation of relapse in multiple sclerosis (MS) is detrimental to the patient as well as to their relationship with their MS healthcare professional (HCP).To obtain direct insight into relapse prevalence, symptoms, and HCP engagement from patie
Autor:
Royce W. Waltrip, Francisca Sivera, Naomi Schlesinger, Cesar Diaz-Torne, Fernando Perez-Ruiz, William J. Taylor, Jasvinder A. Singh, Fiona M McQueen, Nicola Dalbeth, Robert Evans, H. Ralph Schumacher, Rebecca Grainger, N. Lawrence Edwards, Patricia A. MacDonald
Publikováno v:
JOURNAL OF RHEUMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Consensus exercises have identified and prioritized domains of measurement for studies in acute and chronic gout. In parallel, the technical properties of instruments for measurement in many of these domains have been assessed, with the main objectiv
Autor:
Ariane K Kawata, Bill Huang, Maria Greenwald, Allan N. Maroli, Lawrence Edwards, Lori Frank, H. Ralph Schumacher, John S. Sundy, Katy L Benjamin, Peter D. Gorevic, Jeffrey Fessel, Michael Becker, Royce W. Waltrip
Publikováno v:
The Journal of Rheumatology. 36:1041-1048
Objective.The relationship between self-reported quality of life and disability and disease severity was evaluated in subjects with treatment-failure gout (n = 110) in a prospective, 52-week, observational study.Methods.Subjects had symptomatic cryst
Autor:
Larry W. Moreland, André Barkhuizen, William Huang, Pegloticase Phase Study Investigators, Herbert S B Baraf, Allan N. Maroli, Royce W. Waltrip, John S. Sundy, Zeb Horowitz, Michael Becker
Publikováno v:
Arthritis & Rheumatism. 58:2882-2891
Objective To assess the efficacy of pegloticase in achieving and maintaining plasma urate levels of
Autor:
Marika Di Marco, Michelle Alton, Corinne Seng Yue, David Erick Wright, William Huang, Royce W. Waltrip, Allan N. Maroli
Publikováno v:
The Journal of Clinical Pharmacology. 48:708-718
Pegloticase is designed to convert urate into the easily excretable allantoin to treat hyperuricemia in gout. The aim of this analysis was to describe the pharmacokinetics and pharmacodynamics of pegloticase in 40 gout patients. Pegloticase was admin
Autor:
Royce W. Waltrip
Publikováno v:
Schizophrenia Bulletin. 21:173-178
A formal method of evaluation is applied to a theory presented by Drs. Torrey and Yolken, which asserts that cases of viral schizophrenia are due to a zoonosis from house cats. A formal method of theory evaluation is described, and the Torrey and Yol
Autor:
Courtney Holmes, Royce W. Waltrip, Alan Breier, Robert W. Buchanan, Samuel J. Listwak, David S. Goldstein
Publikováno v:
Neuropsychopharmacology. 10:1-7
Clozapine is an atypical neuroleptic medication with superior efficacy to conventional antipsychotic agents for patients with chronic, symptomatic schizophrenia. Neurochemical characteristics that distinguish clozapine from other neuroleptics and con
Autor:
Allan N. Maroli, N. Lawrence Edwards, Robert A. Yood, William Huang, Edward L. Treadwell, Royce W. Waltrip, Zeb Horowitz, William B. White, Peter E. Lipsky, Steven A. Hamburger, Herbert S B Baraf, Janitzia Vázquez-Mellado, Sergio R. Gutierrez-Urena, John S. Sundy, Michael Becker
Publikováno v:
JAMA. 306(7)
Patients with chronic disabling gout refractory to conventional urate-lowering therapy need timely treatment to control disease manifestations related to tissue urate crystal deposition. Pegloticase, monomethoxypoly(ethylene glycol)-conjugated mammal